USA — Evusheld, a preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the United States because it is unlikely to be effective against the coronavirus…
Read MoreTag: AstraZeneca
AstraZeneca strengthens its cardiorenal pipeline with US$1.8B buyout deal of Cincor Pharma
USA— AstraZeneca has struck a deal to buy US-based biopharmaceutical firm CinCor Pharma Inc for up to US$1.8 billion to strengthen its pipeline of heart and kidney drugs and grow…
Read MoreAstraZeneca to discontinue Leukemia drug Lumoxiti in the US market
USA— According to a recent Food and Drug Administration (FDA) communication, Lumoxiti for injection will be permanently discontinued in the US market by August 31, 2023. The FDA approved Lumoxiti,…
Read MorePharma companies AstraZeneca & Pfizer reiterate focus on sustainability
AFRICA – Pharma giants AstraZeneca and Pfizer have reiterated their focus on sustainability with their on-going carbon footprint funding. AstraZeneca has set scope 1 and 2 target featuring carbon emissions…
Read MoreAstraZeneca, G42 Healthcare ink deal to develop innovate drugs in Abu Dhabi
UAE – Biopharma giant AstraZeneca and G42 Healthcare, an AI-powered healthcare company, have teamed up to locally manufacture innovative drugs in the Emirate of Abu Dhabi. The strategic partnership deal…
Read MoreAstraZeneca set to improve liver cancer understanding and care with new research center in Africa
AFRICA – AstraZeneca is set to establish a new liver cancer research partnership in countries in Africa to accelerate improved understanding and care for a form of liver cancer. In…
Read MoreAstraZeneca Pharma India hires Dr. Sanjeev Panchal as Country President, MD
INDIA – AstraZeneca Pharma India Ltd. has appointed Dr. Sanjeev Panchal as Country President and Managing Director for a three-year term beginning January 1, 2023. He succeeds Gagandeep Singh Bedi,…
Read MoreAstraZeneca to expand its healthcare programme to 10 new African countries
AFRICA – AstraZeneca, a multinational pharmaceutical and biotechnology company, has announced a planned expansion of its access to healthcare programme, Healthy Heart Africa (HHA), to 10 new countries, starting in…
Read MoreAstraZeneca to acquire Neogene Therapeutics for up to US$320m in oncology push
UNITED KINGDOM — AstraZeneca is set to acquire biotechnology company Neogene Therapeutics for up to US$320 million as it seeks to build its pipeline of cell-based cancer treatments. Though AstraZeneca’s…
Read MoreUK’s drug discovery company signs US$402m licensing deal with pharma giant AstraZeneca
UNITED KINGDOM — C4X Discovery Holdings (C4XD), based in Manchester, has signed an exclusive global licensing agreement worth up to US$402 million with pharmaceutical giant AstraZeneca. C4XD’s NRF2 Activator program…
Read More